MEURANT
MEURANT has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €145k and a net result of €9k. Equity remains stable across the filed fiscal years (±0.7% per year). Its solvency ranks better than 26% of 4023 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
| Equity | €145k |
| Net result | €9k |
| Staff (FTE) | 3.6 |
| Better than sector | 26% |
Mixed profile: strong on stability, weaker on solvency.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 15.7% | 36.1% | |
| Net result | €9k | €42k | |
| Equity | €145k | €441k | |
| Gross operating margin | €264k | €324k | |
| Staff costs | €178k | €340k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | full schema | full schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €78k | €86k | €37k | €67k | €97k |
| Net profit | €9k | €17k | €-22k | €29k | €46k |
| Cash flow | €52k | €62k | €17k | €47k | €60k |
| Staff costs | €178k | €166k | €144k | €160k | €119k |
| Income taxes | €6k | €586 | €592 | €12k | €19k |
| Dividends | - | - | - | €28k | €30k |
| Total assets | €929k | €934k | €976k | €982k | €913k |
| Equity | €145k | €136k | €119k | €141k | €140k |
| Debt | €783k | €798k | €857k | €841k | €773k |
| of which ≤ 1y | €626k | €614k | €634k | €715k | €730k |
| of which > 1y | €153k | €184k | €223k | €126k | €43k |
| Working capital | €58k | €33k | €9k | €164k | €67k |
| Employees (FTE) | 3.6 | 3.3 | 2.9 | 3.2 | 2.9 |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.09 | 1.05 | 1.01 | 1.23 | 1.09 |
| Quick ratio | 0.78 | 0.74 | 0.70 | 0.95 | 0.83 |
| Working capital ratio | 6.2% | 3.5% | 0.9% | 16.7% | 7.3% |
| Solvency | 15.7% | 14.6% | 12.2% | 14.4% | 15.4% |
| Debt / equity | 5.39 | 5.85 | 7.19 | 5.96 | 5.51 |
| Long-term debt ratio | 1.05 | 1.35 | 1.87 | 0.90 | 0.31 |
| Interest coverage | 3.52 | 3.27 | 1.66 | 5.36 | 4.44 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 1.0% | 1.8% | -2.2% | 2.9% | 5.0% |
| ROE | 6.1% | 12.6% | -18.3% | 20.4% | 32.7% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (24 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €929k | €934k | €976k | €982k | €913k |
| Fixed assets | 21/28 | €245k | €288k | €333k | €104k | €116k |
| Tangible fixed assets | 22/27 | €245k | €288k | €333k | €104k | €116k |
| Current assets | 29/58 | €684k | €646k | €643k | €878k | €797k |
| Stocks & contracts in progress | 3 | €193k | €191k | €200k | €196k | €193k |
| Amounts receivable within one year | 40/41 | €398k | €353k | €311k | €502k | €416k |
| Cash & bank | 54/58 | €91k | €101k | €125k | €180k | €186k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €929k | €934k | €976k | €982k | €913k |
| Equity | 10/15 | €145k | €136k | €119k | €141k | €140k |
| Contributions / capital | 10/11 | €67k | €67k | €67k | €67k | €67k |
| Reserves | 13 | €12k | €12k | €12k | €15k | €15k |
| Accumulated profits (losses) | 14 | €66k | €57k | €40k | €59k | €58k |
| Amounts payable | 17/49 | €783k | €798k | €857k | €841k | €773k |
| Amounts payable after one year | 17 | €153k | €184k | €223k | €126k | €43k |
| Amounts payable within one year | 42/48 | €626k | €614k | €634k | €715k | €730k |
| Trade debts payable within one year | 44 | €283k | €281k | €321k | €426k | €452k |
| Income statement | ||||||
| Gross operating margin | 9900 | €264k | €260k | €184k | €230k | €229k |
| Operating result | 9901 | €35k | €41k | €-2k | €49k | €83k |
| Financial income | 75 | €2k | €3k | €3k | €5k | €3k |
| Financial charges | 65 | €22k | €26k | €22k | €12k | €22k |
| Result before taxes | 9903 | €15k | €18k | €-21k | €41k | €65k |
| Income taxes | 67/77 | €6k | €586 | €592 | €12k | €19k |
| Net result for the period | 9904 | €9k | €17k | €-22k | €29k | €46k |
| Result to be appropriated | 9905 | €9k | €17k | €-19k | €29k | €51k |
-
Françoise DRUARTDirectorState Gazette act 23470354 (21-12-2023)Current21-12-2023 → present
-
Paul Emile Cécil Guillaume MEURANTDirectorState Gazette act 23470354 (21-12-2023)Current21-12-2023 → present
-
PHARMEPPrivate limited companyDirector· perm. rep.: Paul Emile André Ghislain MEURANTState Gazette act 23470354 (21-12-2023)Current21-12-2023 → present
| NACE primary | Retail sale of pharmaceutical products(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 29-07-2010 |
| Status | Active |
| Postal code | 7021 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53038B0414/00P000 | Wallonia | 221 m² | 1 · 134 m² | 13.4 m · 4 fl. |
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
21-12-2023 3 directors appointed
- Paul Emile Cécil Guillaume MEURANT, Bestuurder
- Françoise DRUART, Bestuurder
- Paul Emile André Ghislain MEURANT, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Paul Emile C\u00E9cil Guillaume MEURANT",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "niet_statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale proc\u00E8de imm\u00E9diatement \u00E0 la nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e de : - Monsieur Paul Emile C\u00E9cil Guillaume MEURANT, ci \u2013 avant qualifi\u00E9, ici pr\u00E9sent et qui accepte.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Fran\u00E7oise DRUART",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "niet_statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale proc\u00E8de imm\u00E9diatement \u00E0 la nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e de : - Madame Fran\u00E7oise DRUART, ci \u2013 avant qualifi\u00E9e, ici pr\u00E9sente et qui accepte.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Paul Emile Andr\u00E9 Ghislain MEURANT",
"address": null,
"birth_date": "1980-10-11",
"profession": null,
"birth_place": "Mons"
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0830.777.581",
"name": "PHARMEP",
"address": "7021 Mons, Chauss\u00E9e du Roeulx, 1188",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB PHARMEP \u00BB, dont le si\u00E8ge est \u00E9tabli \u00E0 7021 Mons, Chauss\u00E9e du Roeulx, 1188, immatricul\u00E9e \u00E0 la Banque Carrefour des Entreprises sous le num\u00E9ro BE 0830.777.581. Dont le repr\u00E9sentant permanent est Monsieur MEURANT Paul Emile Andr\u00E9 Ghislain, n\u00E9 \u00E0 Mons le 11 octobre 1",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_pending",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Paul Emile C\u00E9cil Guillaume MEURANT",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cidera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge aux g\u00E9rants d\u00E9missionnaires pour l\u2019ex\u00E9cution de leur mandat.",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_pending",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Fran\u00E7oise DRUART",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cidera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge aux g\u00E9rants d\u00E9missionnaires pour l\u2019ex\u00E9cution de leur mandat.",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Edmond-Charles BOUTTIAU",
"firm_city": null,
"firm_name": null,
"office_city": "Qu\u00E9vy",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-12-21",
"filing_date": "2023-12-19",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0828.366.340",
"name_full": "MEURANT",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Edmond-Charles BOUTTIAU",
"org_rep_person_name": null,
"person_role_at_subject": "Notaire"
},
"co_filed_documents": [
"Une exp\u00E9dition de l\u0027AGE du 11 d\u00E9cembre 2023",
"les statuts coordonn\u00E9s"
],
"corrected_publication_numac": null
}| Legal nameFR | MEURANT |